Publicaciones en colaboración con investigadores/as de Royal Brisbane and Women's Hospital (1)

2009

  1. TRIO-012: A multicenter, multinational, randomized, double-blind phase iii study of imc-1121b plus docetaxel versus placebo plus docetaxel in previously untreated patients with her2-negative, unresectable, locally recurrent or metastatic breast cancer

    Clinical Breast Cancer, Vol. 9, Núm. 4, pp. 258-261